Modulation of the cellular and humoral immune response to pediatric open heart surgery by methylprednisolone

With the intention to reduce overshooting immune response, glucocorticoids are frequently administered perioperatively in children undergoing open heart surgery. In a retrospective study we investigated extensively the modulation of the humoral and cellular immune response by methylprednisolone (MP).

[1]  A. Chang,et al.  Steroids and low cardiac output syndrome after cardiac surgery in children. , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[2]  L. Casey.  Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. , 1993, The Annals of thoracic surgery.

[3]  U. Sack,et al.  Age-Related Lymphocyte Subset Changes in the Peripheral Blood of Healthy Children – a Meta-Study , 2007, Transfusion Medicine and Hemotherapy.

[4]  A. Puech,et al.  Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects. , 2001, British journal of clinical pharmacology.

[5]  A. Kagey‐Sobotka,et al.  Corticosteroid modulation of human, antigen-specific Th1 and Th2 responses. , 1997, The Journal of allergy and clinical immunology.

[6]  C. Wippermann,et al.  Changes in lymphocyte subsets after cardiac surgery in children , 2002, European Journal of Pediatrics.

[7]  K. Thorlund,et al.  Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials. , 2008, European heart journal.

[8]  L. Dibbelt,et al.  Persistent endocrine stress response in patients undergoing cardiac surgery , 1998, Journal of endocrinological investigation.

[9]  G. von Bernuth,et al.  Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure. , 1993, The Journal of thoracic and cardiovascular surgery.

[10]  Attila Tárnok,et al.  Inflammation and Immune Suppression following Protein Losing Enteropathy after Fontan Surgery Detected by Cytomics , 2007, Transfusion Medicine and Hemotherapy.

[11]  Attila Tárnok,et al.  Preoperative prediction of pediatric patients with effusions and edema following cardiopulmonary bypass surgery by serological and routine laboratory data , 2002, Critical care.

[12]  S. Yao,et al.  Capillary leak syndrome in children with C4A-deficiency undergoing cardiac surgery with cardiopulmonary bypass: a double-blind, randomised controlled study , 2005, The Lancet.

[13]  M. Masuda,et al.  Synergistic immunosuppression caused by high-dose methylprednisolone and cardiopulmonary bypass. , 1997, The Annals of thoracic surgery.

[14]  G. von Bernuth,et al.  Effect of sodium nitroprusside on complement activation induced by cardiopulmonary bypass: a clinical and experimental study. , 1996, The Journal of thoracic and cardiovascular surgery.

[15]  A. Mittag,et al.  Concepts for Absolute Immunophenosubtyping by Slide- Based Cytometry , 2007, Transfusion Medicine and Hemotherapy.

[16]  J. Osredkar,et al.  Methylprednisolone, cortisol and the cell-mediated immune response in children after ventricular septal defect repair , 2007, Clinical chemistry and laboratory medicine.

[17]  E. Schmid,et al.  Administration of Steroids in Pediatric Cardiac Surgery: Impact on Clinical Outcome and Systemic Inflammatory Response , 2005, Pediatric Cardiology.

[18]  M. Roederer,et al.  Data analysis in flow cytometry: The future just started , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[19]  A. Tárnok,et al.  Pediatric cardiac surgery with cardiopulmonary bypass: pathways contributing to transient systemic immune suppression. , 2001, Shock.

[20]  L. Lindberg,et al.  Effects of dexamethasone on clinical course, C-reactive protein, S100B protein and von Willebrand factor antigen after paediatric cardiac surgery. , 2003, British journal of anaesthesia.

[21]  M. Podbregar,et al.  Skeletal muscle oxygen saturation does not estimate mixed venous oxygen saturation in patients with severe left heart failure and additional severe sepsis or septic shock , 2007, Critical care.

[22]  J. Vincent,et al.  Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. , 1997, Chest.

[23]  J. Copeland,et al.  The effect of methylprednisolone treatment on the cardiopulmonary bypass-induced systemic inflammatory response. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[24]  D. Nelson,et al.  Steroid use before pediatric cardiac operations using cardiopulmonary bypass: An international survey of 36 centers* , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[25]  C. Mavroudis,et al.  Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children. , 2000, The Annals of thoracic surgery.

[26]  V. Gold.  Compendium of chemical terminology , 1987 .

[27]  T. Clemmer,et al.  A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. , 1987, The New England journal of medicine.

[28]  J. Zimmerman,et al.  Pediatric Multiple Organ Dysfunction Syndrome , 2006 .

[29]  F. Holsboer,et al.  Intracellular Molecular Signaling , 2009, Annals of the New York Academy of Sciences.

[30]  G. Hill.  The Inflammatory Response to Cardiopulmonary Bypass , 1996, International anesthesiology clinics.

[31]  Helmut E Meyer,et al.  Approaching clinical proteomics: Current state and future fields of application in cellular proteomics , 2009, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[32]  M. Elliott.  Modified ultrafiltration and open heart surgery in children , 1999, Paediatric anaesthesia.

[33]  A. Tárnok,et al.  Protein-losing enteropathy in patients with Fontan circulation: is it triggered by infection? , 2003, Critical care.

[34]  Myocardial protection in sepsis , 2008, Critical care.

[35]  H. Gilliland,et al.  The effect of aprotinin on interleukin‐8 concentration and leukocyte adhesion molecule expression in an isolated cardiopulmonary bypass system , 1999, Anaesthesia.

[36]  M. Quintel,et al.  Cardiopulmonary and systemic effects of methylprednisolone in patients undergoing cardiac surgery. , 2007, The Annals of thoracic surgery.

[37]  D. Nelson,et al.  Combined Steroid Treatment for Congenital Heart Surgery Improves Oxygen Delivery and Reduces Postbypass Inflammatory Mediator Expression , 2003, Circulation.

[38]  U. Welsch,et al.  Hydrocortisone Preserves the Vascular Barrier by Protecting the Endothelial Glycocalyx , 2007, Anesthesiology.

[39]  J. Vincent.  Understanding cardiac output , 2008, Critical care.

[40]  K. Tokel,et al.  Systemic Inflammatory Response Related to Cardiopulmonary Bypass and Its Modification by Methyl Prednisolone: High Dose Versus Low Dose , 2002, Pediatric Cardiology.

[41]  M. El Barbary,et al.  Prophylactic steroids for pediatric open heart surgery. , 2007, The Cochrane database of systematic reviews.

[42]  Attila Tárnok,et al.  Quality Control and Standardization , 2009 .

[43]  F. Mohr,et al.  Changes of Leukocyte Subsets in Coronary Artery Bypass Surgery: Cardiopulmonary Bypass Versus ‘Off-pump’ techniques , 1998, The Thoracic and cardiovascular surgeon.

[44]  Donald J. Birkett,et al.  Pharmacokinetics Made Easy , 1999 .

[45]  G. Hill.  Cardiopulmonary bypass-induced inflammation: is it important? , 1998, Journal of cardiothoracic and vascular anesthesia.

[46]  M. Chaney.  Corticosteroids and cardiopulmonary bypass : a review of clinical investigations. , 2002, Chest.

[47]  C. E. Pedreira,et al.  Generation of flow cytometry data files with a potentially infinite number of dimensions , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[48]  Andreas Thiel,et al.  From transcriptome to cytome: Integrating cytometric profiling, multivariate cluster, and prediction analyses for a phenotypical classification of inflammatory diseases , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[49]  A. Tárnok,et al.  Neutrophil Adhesion Molecule Expression and Serum Concentration of Soluble Adhesion Molecules during and after Pediatric Cardiovascular Surgery with or without Cardiopulmonary Bypass , 2002, Anesthesiology.

[50]  A Tárnok,et al.  Potential of a cytomics top-down strategy for drug discovery. , 2010, Current medicinal chemistry.

[51]  Attila Tárnok,et al.  Basics of standardization and calibration in cytometry – a review , 2009, Journal of biophotonics.

[52]  A. Tárnok,et al.  Soluble endothelial adhesion molecules during paediatric cardiovascular surgery with or without cardiopulmonary bypass , 2002, Cardiology in the Young.

[53]  G. Dreyfus,et al.  Will Off-Pump Coronary Artery Surgery Replace Conventional Coronary Artery Surgery? , 2004, Journal of the Royal Society of Medicine.

[54]  K. Bochennek,et al.  Age‐matched lymphocyte subpopulation reference values in childhood and adolescence: application of exponential regression analysis , 2008, European journal of haematology.

[55]  A. Darzi,et al.  The inflammatory response to cardiopulmonary bypass: part 2--anti-inflammatory therapeutic strategies. , 2009, Journal of cardiothoracic and vascular anesthesia.

[56]  M. Bøgsted,et al.  Multiparametric flow cytometry profiling of neoplastic plasma cells in multiple myeloma , 2010, Cytometry. Part B, Clinical cytometry.

[57]  H. Suzuki,et al.  85; RELATIONSHIP BETWEEN CHANGES IN COMPLEMENT SYSTEM, and HEPATIC MITOCHONDRIAL REDOX POTENTIAL IN SEPTIC PATIENTS , 1994 .